Showing results (401-410 of 676) with videos related to

Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|February 6, 2009
Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancerCindy Gaston, Jill Kolesar
Clinical Advances in Hematology & Oncology : H&O|February 12, 2009
Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategiesAsh A Alizadeh, Ranjana H Advani
Clinical Advances in Hematology & Oncology : H&O|November 11, 2008
The role of cetuximab for the treatment of squamous cell carcinoma of the head and neckRanee Mehra, Roger B Cohen, Barbara A Burtness
Clinical Advances in Hematology & Oncology : H&O|April 14, 2010
First-line use of EGFR tyrosine kinase inhibitors in patients with NSCLC containing EGFR mutationsJoel W Neal, Lecia V Sequist
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
Chemotherapy resistance abrogation in metastatic melanomaHussein A Tawbi, Shama C Buch
Clinical Advances in Hematology & Oncology : H&O|June 13, 2009
The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F eraHuichun Zhan, Jerry L Spivak
Clinical Advances in Hematology & Oncology : H&O|June 20, 2009
Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin BRomuald Bellmann, John D Cleary, Jaroslav Sterba
Clinical Advances in Hematology & Oncology : H&O|August 25, 2009
Treatment of locally advanced non-small cell lung cancerMary Jo Fidler, Anthony W Kim, Thomas Zusag, et al.
Clinical Advances in Hematology & Oncology : H&O|August 25, 2009
Transient hyperglycemia during childhood acute lymphocytic leukemia chemotherapy: an old event revisitedAngela Maria Spinola-Castro, Adriana Aparecida Siviero-Miachon, Solange Andreoni, et al.
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Molecularly targeted agents for renal cell carcinoma: the next generationC Lance Cowey, Thomas E Hutson
Pageof 68